COMMUNIQUÉS West-GlobeNewswire

CrownBio Expands Novel Humanized Models for Targeted Immunotherapy Development to San Diego, CA Research Center

27/07/2018 - 10:24

Humanized Model Expansion Program begins with PD-1, CTLA-4, and CD137 Models SAN DIEGO, July 27, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a global drug discovery and development services company providing [...]

Status of Orphan designation of Apealea in the European Union

27/07/2018 - 08:50

Oasmia Pharmaceutical AB (NASDAQ: OASM) herewith announces that Apealea was designated as an orphan medicine by the European Commission in 2006 and alongside the procedure of the application for assessing a Market [...]

Chi-Med Reports 2018 Interim Results and Updates Shareholders on Key Clinical Programs

27/07/2018 - 08:00

LONDON, July 27, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM:HCM) (Nasdaq:HCM) today announces its unaudited financial results for the six months ended June 30, 2018 and updates [...]

DBV Technologies Reports June 30, 2018 Cash Position

27/07/2018 - 07:31

Montrouge, France, July 27, 2018 DBV Technologies Reports June 30, 2018 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced its cash and cash equivalents as of [...]

DBV Technologies publie sa position de trésorerie au 30 Juin 2018

27/07/2018 - 07:31

Montrouge, France, le 27 Juillet (7H30 CEST), 2018 DBV Technologies publie sa position de trésorerie au 30 Juin 2018 DBV Technologies, (Euronext: DBV - ISIN : FR0010417345 - NASDAQ : DBVT), société biopharmaceutique [...]

Lefebvre family inspired by Terry Fox while walking across Canada for cancer research

27/07/2018 - 07:11

HALLVILLE, Ontario, July 26, 2018 (GLOBE NEWSWIRE) -- On May 1, Jimmy Lefebvre and his family left his parents’ home in Grande Prairie, Alberta to embark on a 5,700-kilometre walk across Canada in honour of his late [...]

Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $50 Million

27/07/2018 - 02:00

DUBLIN, Ireland and KING OF PRUSSIA, Pa., July 26, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV) today announced the pricing of its underwritten public offering of 18,181,818 ordinary shares at a [...]

Scythian Biosciences Announces Director Resignation

27/07/2018 - 00:52

TORONTO, July 26, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (to be renamed Sol Global Investments Corp.) (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) today announced [...]

Adherium Receives Additional U.S. FDA 510(k) Clearance, Setting in Motion a Full U.S. Consumer Launch of the Hailie™ Solution

27/07/2018 - 00:34

SAN MATEO, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health platform that improves medication adherence, patient outcomes and engagement, today announced the U.S. Food and [...]

National Research Corporation to Broadcast its 2018 Second Quarter Conference Call Live on the Internet

26/07/2018 - 23:00

Lincoln, Nebraska, July 26, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2018 second quarter earnings conference call on [...]

Dyadic International to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018

26/07/2018 - 22:30

JUPITER, Fla., July 26, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help [...]

Bioblast Pharma Ltd. Corporate and Management Update

26/07/2018 - 22:15

TEL AVIV, Israel and NEW YORK, July 26, 2018 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (Nasdaq:ORPN) is providing an update on business development activities as well as notice of an organization change that affects [...]

ContraFect Corporation Announces Proposed Public Offering of Common Stock

26/07/2018 - 22:12

YONKERS, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug- [...]

Intercept to Announce Second Quarter 2018 Financial Results on August 2, 2018 and Present at Upcoming Investor Conference

26/07/2018 - 22:05

NEW YORK, July 26, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

Chembio Diagnostics to Participate in the Canaccord Genuity Growth Conference

26/07/2018 - 22:05

MEDFORD, N.Y., July 26, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic testing, today announced the Company plans to participate in the upcoming Canaccord [...]

Dova Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 9, 2018

26/07/2018 - 22:05

DURHAM, N.C., July 26, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) will host a conference call on Thursday, August 9, 2018 at 4:30 p.m. ET to discuss second quarter 2018 financial results and [...]

electroCore, Inc. to Report Second Quarter Financial Results on August 13, 2018

26/07/2018 - 22:05

BASKING RIDGE, N.J., July 26, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced that it will release financial results for the [...]

Loop Industries Expands Into Cosmetics Sector With L’Oréal Group

26/07/2018 - 22:05

TERREBONNE, Quebec, July 26, 2018 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq:LOOP), a global leader in sustainable packaging innovation, announced that it has signed a Letter of Intent with L’Oréal Group, the [...]

LeMaitre Q2 2018 Record Sales $27.0mm (+5%), Record EPS $0.43 (+86%)

26/07/2018 - 22:05

BURLINGTON, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2018 results, provided guidance and announced a $0.07/ [...]